Tevarak Deals announced worldwide in 2024 totaled $846.8 billion as of Sept. 25, up 14% from the year-earlier period, Dealogic data showed.
Of that, U.S. M&A volume was down 8% to $338 billion, with stock gyrations, regulatory scrutiny and rates putting a dampener on activity.
.
